Inostamycin prevents malignant phenotype of cancer: Inhibition of phosphatidylinositol synthesis provides a therapeutic advantage for head and neck squamous cell carcinoma
Dive into the research topics of 'Inostamycin prevents malignant phenotype of cancer: Inhibition of phosphatidylinositol synthesis provides a therapeutic advantage for head and neck squamous cell carcinoma'. Together they form a unique fingerprint.